Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/90465
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Harford-Wright, E. | - |
dc.contributor.author | Lewis, K. | - |
dc.contributor.author | Vink, R. | - |
dc.contributor.author | Ghabriel, M.N. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Neuroscience, 2014; 261:85-94 | - |
dc.identifier.issn | 0306-4522 | - |
dc.identifier.issn | 1873-7544 | - |
dc.identifier.uri | http://hdl.handle.net/2440/90465 | - |
dc.description.abstract | Abstract not available | - |
dc.description.statementofresponsibility | E. Harford-Wright, K. M. Lewis, R. Vink and M. N. Ghabriel | - |
dc.language.iso | en | - |
dc.publisher | Elsevier | - |
dc.rights | © 2014 IBRO. Published by Elsevier Ltd. All rights reserved. | - |
dc.source.uri | http://dx.doi.org/10.1016/j.neuroscience.2013.12.027 | - |
dc.subject | Neuropeptides; brain tumors; NK1 antagonist; substance P; cancer therapy | - |
dc.title | Evaluating the role of substance P in the growth of brain tumors | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1016/j.neuroscience.2013.12.027 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Vink, R. [0000-0002-4885-0667] | - |
dc.identifier.orcid | Ghabriel, M.N. [0000-0002-9153-271X] | - |
Appears in Collections: | Aurora harvest 7 Medical Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.